Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Palbomed 125mg Capsule
Manufacturer/Marketed By : MEDICAMEN BIOTECH LTD
$143.75 $49.92
Sidmex Inovia offers bulk export supply of Palbomed 125mg Capsule (PALBOCICLIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
PALBOCICLIB
Active Pharmaceutical Ingredient
Palbomed 125mg Capsule
$143.75
$49.92
Sidmex Inovia offers bulk export supply of Palbomed 125mg Capsule (PALBOCICLIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Palbomed 100mg Capsule
Palbomed 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. Palbomed 125 uses include its role in slowing down cancer cell growth and prolonging progression-free survival in patients with this subtype of breast cancer. palbomed capsule is a generic formulation of palbociclib used in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer. While Palbomed is one palbociclib-based option, some patients and healthcare providers also compare it with Pabreca, another formulation of palbociclib. Discussions around pabreca breast cancer usage often focus on its role in similar HR-positive, HER2-negative metastatic breast cancer cases. When evaluating pabreca vs palbociclib brand efficacy, current evidence suggests comparable therapeutic outcomes, although individual responses may vary. Additionally, the palbomed 125mg price may differ depending on the pharmacy and region, and cost considerations often influence treatment decisions. The typical Palbomed dosage is 125 mg taken once daily for 21 days, followed by a 7-day break, completing a 28-day treatment cycle. Dosage adjustments may be made by your doctor based on your tolerance and blood test results. Palbomed 125mg price is varies on retailer and location. palbociclib substitutes in India include Ciclib, Bdpalbo, Palnat, Pabreca, Kixta, Piciclib, PALENO, and Palborest, while alternative CDK4/6 inhibitors are Abemaciclib (Verzenio) and Ribociclib (Kisqali).
Active Pharmaceutical Ingredient
Uses
• Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
palbociclib side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. palbomed 125mg capsule side effects include
Most Common Side Effects
• Tiredness
• Hair loss
• Dry skin, rash
• Infections
• Low blood cell counts
• Decreased of appetite
• Nausea, vomiting
• Diarrhea
• Swelling of lips and mouth
• Changes in taste
• Nose bleed
• Dry eye, blurred vision, increased tearing
Common Side Effects
• Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
• Lung inflammation (chest pain, dry cough, or difficulty breathing)
How To Use
Take Palbomed 125 mg Capsule exactly as prescribed by your doctor. Take this medication once a day at the same time as food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Safety Advice
• Breast Feeding: It is not recommended to take Palbomed 125 mg Capsule while breastfeeding as it is not known whether it passes into the breast milk.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Palbomed 125 mg Capsule. Check with your doctor for advice.
• Liver: Inform your physician if you have any liver disorders before taking Palbomed 125 mg Capsule, as it should be used with caution in liver disorder patients.
• Lungs: It is not unknown whether palbomed 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Palbomed 125 mg Capsule can cause tiredness. Avoid driving if you are unwell.
• Pregnancy: It is not recommended to take Palbomed 125 mg Capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.